In This Section

Board of Directors

John D. Carpten, PhD, FAACR

John D. Carpten, PhD, FAACR

(2021-2025)

Chief Scientific Officer
Director’s Distinguished Chair, Irell and Manella Cancer Center
Morgan and Helen Chu Director’s Chair, Beckman Research Institute
Director, Comprehensive Cancer Center
Director, Beckman Research Institute
City of Hope
Duarte, California

John M. Carethers, MD, FAACR

John M. Carethers, MD, FAACR

(2023-2026)

Vice Chancellor for Health Sciences
University of California San Diego
San Diego, California

Christina Curtis, PhD, MSc

Christina Curtis, PhD, MSc

(2022-2025)

Professor of Medicine, Genetics, and Biomedical Data Science
Director, Breast Cancer Translational Research
Co-director, Molecular Tumor Board
Stanford University
Investigator, Chan Zuckerberg Biohub
Stanford, California

Manuel Hidalgo, MD, PhD

Manuel Hidalgo, MD, PhD

(2024-2027)

Professor of Medicine
Walter B. Wriston Professor of Pancreatic Cancer Research, Harvard Medical School
Chief, Division of Hematology and Medical Oncology, Joan and Sanford I. Weill Department of Medicine
Sandra and Edward Meyer Cancer Center
Weill Cornell Medicine
New York, New York

Christine M. Lovly, MD, PhD

Christine M. Lovly, MD, PhD

(2023-2026)

Associate Professor of Medicine, Division of Hematology-Oncology
Ingram Associate Professor of Cancer Research
Co-leader, Translational Research and Interventional Oncology Program
Vanderbilt University Medical Center
Vanderbilt Ingram Cancer Center
Nashville, Tennessee

William Pao, MD, PhD

William Pao, MD, PhD

(2022-2025)

Chief Executive Officer
Revelio Therapeutics, Inc.
New York, New York

Electra D. Paskett, PhD

Electra D. Paskett, PhD

(2024-2027)

Marion N. Rowley Professor of Cancer Research
Director, Division of Cancer Prevention and Control, Department of Internal Medicine
Distinguished Professor, College of Medicine
Professor, Division of Epidemiology, College of Public Health
Deputy Director for Population Sciences and Community Outreach
Founding Director, Center for Cancer Health Equity
James Cancer Hospital
The Ohio State University
Columbus, Ohio

Elizabeth A. Platz, ScD, MPH

Elizabeth A. Platz, ScD, MPH

(2023-2026)

Professor and Martin D. Abeloff, MD, Scholar in Cancer Prevention
Department of Epidemiology
Johns Hopkins Bloomberg School of Public Health
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Baltimore, Maryland

Katerina A. Politi, PhD

Katerina A. Politi, PhD

(2024-2027)

Professor of Pathology
Co-Leader, Cancer Signaling Networks
Scientific Director, Center for Thoracic Cancers
Yale Cancer Center
Yale School of Medicine
New Haven, Connecticut

Alice T. Shaw, MD, PhD

Alice T. Shaw, MD, PhD

(2023-2026)

Chief, Strategic Partnerships
Dana Farber Cancer Institute
Boston, Massachusetts

Jean-Charles Soria, MD, PhD

Jean-Charles Soria, MD, PhD

(2024-2027)

Senior Vice President of Oncology, Global Development
Amgen
Thousand Oaks, California

Kimberly Stegmaier, MD

Kimberly Stegmaier, MD

(2022-2025)

Professor of Pediatrics at Harvard Medical School
Ted Williams Investigator, Dana-Farber Cancer Institute
Boston, Massachusetts

Robert H. Vonderheide, MD, DPhil

Robert H. Vonderheide, MD, DPhil

(2022-2025)

Director, Abramson Cancer Center
Vice Dean and Vice President of Cancer Programs
Perelman School of Medicine and the University of Pennsylvania Health System
Philadelphia, Pennsylvania

Jedd Wolchok, MD, PhD, FASCO, FAACR

Jedd Wolchok, MD, PhD, FASCO, FAACR

(2023-2026)

Director, Sandra and Edward Meyer Cancer Center
Professor of Medicine
Weill Cornell Medicine
New York, New York

Catherine J. Wu, MD, FAACR

Catherine J. Wu, MD, FAACR

(2024-2027)

Professor of Medicine
Chief, Division of Stem Cell Transplantation and Cellular Therapies
Lavine Family Chair for Preventative Cancer Therapies
Dana-Farber Cancer Institute
Boston, Massachusetts

View the list of past board members.